Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patients
Not Applicable
Recruiting
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000011129
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
High risk for bleeding Liver dysfunction Renal failure Pregnancy severe infection and trauma, perioperation Treatment with HIV protease inhibitors Treatment with azole antifungal agents History of allergy to rivaroxaban Ineligible in the opinion of investigators
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of inflammatory cytokine Transition of blood coagulation and fibrinolysis
- Secondary Outcome Measures
Name Time Method Evaluation of IMT by carotid artery echo Evaluation of atherosclerotic plaque volume and character